A Novel Method for Efficient Preparation of Mucosal Adjuvant Escherichia coli Heat-Labile Enterotoxin Mutant (LTm) by Artificially Assisted Self-Assembly In Vitro.

Applied Biochemistry and Biotechnology
Di LiuXingyuan Ma

Abstract

As well-known powerful mucosal adjuvant proteins, Escherichia coli heat-labile enterotoxin (LT) and its non-toxic or low-toxic mutants (LTm) are capable of promoting strong mucosal immune responses to co-administered antigens in various types of vaccines. However, due to the complex composition and special structure, the yield of LTm directly from the recombinant genetic engineering strains is quite low. Here, we put forward a novel method to prepare LTm protein which designed, expressed, and purified three kinds of component subunits respectively and assembled them into a hexamer structure in vitro by two combination modes. In addition, by simulated in vivo environment of polymer protein assembly, the factors of the protein solution system which include environment temperature, pH, ionic strength of the solution, and ratio between each subunit were taken into consideration. Finally, we confirmed the optimal conditions of two assembly strategies and prepared the hexamer holotoxin in vitro. These results are not only an important significance in promoting large-scale preparation of the mucosal adjuvant LTm but also an enlightening to produce other multi-subunit proteins.

References

Dec 1, 1996·Journal of Biomolecular NMR·R A LaskowskiJ M Thornton
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·D M Huang, D Chandler
Nov 6, 2004·Nature Biotechnology·François Baneyx, Mirna Mujacic
Jan 7, 2005·Applied Microbiology and Biotechnology·S Jana, J K Deb
Mar 8, 2005·The Journal of Dairy Research·Stéphanie Bordenave-JuchereauFrédéric Sannier
Sep 13, 2006·FEMS Immunology and Medical Microbiology·Melissa Ang Simões LasaroLuís Carlos de Souza Ferreira
Oct 3, 2006·Biotechnology and Bioengineering·Andrea VeraAntonio Villaverde
Jun 9, 2009·Biotechnology Advances·Arnold L Demain, Preeti Vaishnav
Nov 7, 2009·Methods in Enzymology·William H Brondyk
Dec 18, 2010·Vaccine·Vanusa P da HoraDenise L Doolan
Feb 4, 2011·Clinical and Vaccine Immunology : CVI·Elizabeth B NortonJohn D Clements
Jul 22, 2011·Nature·F Ulrich HartlManajit Hayer-Hartl
Oct 3, 2012·Advanced Drug Delivery Reviews·Xiaoying ChenWei-Chiang Shen
Jul 31, 2013·The Protein Journal·Gopal Jee Gopal, Awanish Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.